Effects of haloperidol and probenecid on plasma and CSF dopamine metabolites in the rhesus monkey (Macacca mulatta).
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D004298:Dopamine / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology*; D000882:Haplorhini; D006719:Homovanillic Acid / Q000378:metabolism; D008253:Macaca mulatta; D008297:Male; D011339:Probenecid / Q000494:pharmacology*; D013217:Starvation / Q000378:metabolism; D013997:Time Factors
D015102:3,4-Dihydroxyphenylacetic Acid; D006220:Haloperidol; D011339:Probenecid; D004298:Dopamine; D006719:Homovanillic Acid